Better moods, higher concentration levels, more creativity - and all without the usual risks associated with hard drugs: Proponents of microdosing LSD - taking tiny fractions of the amount needed for ...

A landmark clinical trial testing the effect of microdosing LSD on symptoms of attention-deficit hyperactive disorder (ADHD) recently delivered its first data readout and the results have been ...

LSD has shown promise for treating conditions like depression, but it might not do much for ADHD. © cybermagician via Shutterstock LSD can do a lot of things, but ...

MindBio Therapeutics Corp. said that “MB22001, a proprietary and self-titratable form of Lysergic Acid Diethylamide (LSD) designed for safe take home microdosing” has been approved for take-home use ...

In a recent study published in the journal Translational Psychiatry, researchers from New Zealand conducted a phase I trial to assess the effect of micro-dosing of lysergic acid diethylamide (LSD) on ...

Twice-weekly microdoses of LSD were no more effective than a placebo in treating ADHD symptoms. However, the researchers suggest that alternative strategies, such as daily dosing, alternate-day dosing ...

Taking small, repeated doses of the psychedelic drug LSD doesn’t alleviate ADHD symptoms any more than a placebo. To test the drugs’ effects on ADHD more rigorously, Matthias Liechti at the University ...

Low doses of the psychedelic drug LSD increase complexity in the brain, even when they don’t alter a person’s consciousness. The finding challenges the idea that these two phenomena are correlated and ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks of ...